New drug combo hopes to ease myelofibrosis symptoms
Disease control
Recruiting now
This early-phase study tests a new drug (imetelstat) added to the standard treatment (ruxolitinib) for people with myelofibrosis, a rare bone marrow cancer. The goal is to find the best dose and see if the combination safely reduces symptoms like fatigue and spleen discomfort. Ab…
Phase: PHASE1 • Sponsor: Geron Corporation • Aim: Disease control
Last updated May 15, 2026 11:56 UTC